AR Systems Names New Distributors in Europe, Expanding Its Global Distribution Network
SOUDERTOWN, Pa., Sept. 19, 2023 (GLOBE NEWSWIRE) — AR Systems, a worldwide leader in microwave…
SOUDERTOWN, Pa., Sept. 19, 2023 (GLOBE NEWSWIRE) — AR Systems, a worldwide leader in microwave…
NEW YORK, NY / ACN Newswire / September 19, 2023 / InSyBio, a leading biotechnology…
PALO ALTO, CA / ACN Newswire / September 19, 2023 / Dazz, the global leader…
MUMBAI, INDIA, Sept 19, 2023 – (ACN Newswire) – StrategINK Solutions Private Limited will host…
Trusted personal finance website investor.com is proud to announce it is the new home of…
Procore Copilot will help customers make the next best decision by leveraging advanced artificial intelligence…
‘There’s No Room for Tobacco in a Net Zero World’ NEW YORK–(BUSINESS WIRE)–Tobacco Free Portfolios…
LONDON–(BUSINESS WIRE)–#Rocket–A team of university students in London is preparing to launch the most powerful…
New Proprietary AI Enabled Process Helps Reduce CAD Model Creation Times from Hours to Seconds Rochester,…
Discern Security launches with a $3m funding round as it enhances the performance of cybersecurity…
– Research study demonstrates regulation of chromatin structure and cancer gene expression – – Findings…
– Research study demonstrates regulation of chromatin structure and cancer gene expression – – Findings…
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test…
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test…
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
The only FDA-cleared multi-target biothreat product developed and manufactured by a U.S. owned company LEXINGTON,…
The only FDA-cleared multi-target biothreat product developed and manufactured by a U.S. owned company LEXINGTON,…
FORT LEE, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority-owned subsidiary…
FORT LEE, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority-owned subsidiary…